K Pavithran

Professor of Medical Oncology, Amrita Institute of Medical Sciences. Oncologist and Hematologist

[K Pavithran @drkpavithran]

Our new paper, "Projection of age-standardised mortality rates for 23 cancer types in India: a nationwide projection until 2030 using autoregressive integrated moving average (ARIMA) models"
https://t.co/J7WNGaToRr

[K Pavithran @drkpavithran]

Diagnosis and treatment of Burkitt lymphoma in adults: clinical practice guidelines from ERN-EuroBloodNet
https://t.co/m4qO8CxStO

[K Pavithran @drkpavithran]

Our study on the clinical outcomes between FIGO 2009 and 2023 staging for endometrial cancer—a single institution retrospective study
https://t.co/NbQPHdyJOp

[K Pavithran @drkpavithran]

Perioperative FLOT improves survival among patients with resectable esophageal adenocarcinoma- ESOPEC trial
https://t.co/81lXJ0qQm8

[K Pavithran @drkpavithran]

Vaccines for cancer prevention
https://t.co/icS0yIeFmm

[K Pavithran @drkpavithran]

AML management 2025
https://t.co/ZEms04V46c

[K Pavithran @drkpavithran]

Economic burden of breast cancer in India, 2000-2021 and forecast to 2030
https://t.co/D9g3dLy6Iv

[K Pavithran @drkpavithran]

Vaccination of adults with cancer: ASCO Guideline
https://t.co/d1ifEoWpgB

[K Pavithran @drkpavithran]

Management of adverse events associated with lorlatinib
https://t.co/hL1adULrqM

[K Pavithran @drkpavithran]

Hairy cell leukemia 2024
https://t.co/hG1bYgHAWJ

[K Pavithran @drkpavithran]

Therapy for stage IV NSCLC with driver alterations: ASCO living guideline
https://t.co/ksjQVXYdRS

[K Pavithran @drkpavithran]

Therapy for stage IV NSCLC without driver alterations: ASCO living guideline
https://t.co/uizjtq8BKj

[K Pavithran @drkpavithran]

Proposed lung cancer TNM stage groups in the 9th edition of the TNM by IASLC
https://t.co/XbcmqjGkpC

[K Pavithran @drkpavithran]

Diagnosis, prognostic factors, and assessment of ALL in adults- ELN recommendations - 2023
https://t.co/XkFYVqehak

[K Pavithran @drkpavithran]

CAR-macrophage versus CAR-T for solid tumors
https://t.co/P1Fes8OBIN

[K Pavithran @drkpavithran]

Systemic treatment of patients with metastatic breast cancer: ASCO Resource–stratified guideline
https://t.co/GWsGO4kXff

[K Pavithran @drkpavithran]

Nelarabine: in the treatment of T-ALL- when and how?
https://t.co/Ou6mAn9J1i

[K Pavithran @drkpavithran]

Germline testing in patients with breast cancer: ASCO–SSO Guideline
https://t.co/04NJ6UtyQI

[K Pavithran @drkpavithran]

Patterns of cancer burden in Asia, 1990–2019
https://t.co/DOoHjQxKop

[K Pavithran @drkpavithran]

In pancreatic adenocarcinoma, 68Ga-FAPI PET-CT's detection rate and diagnostic accuracy are superior to 18F-FDG PET-CT
https://t.co/pxKdce2Eu5